BDBM290276 3,4-Dimethyl-8-(piperidin-4-yl)pyrimido[1′,2′:1,5]pyrazolo[3,4-c]pyridazin-6(5H)-one hydrochloride::US10098883, Example 17::US10668071, Example 17

SMILES Cc1nnc2nn3c(cc(=O)[nH]c3c2c1C)C1CCNCC1

InChI Key InChIKey=YYFWEPCJQMLKDX-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 290276   

TargetPlasminogen [101-181](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM290276(US10098883, Example 17 | 3,4-Dimethyl-8-(piperidin...)
Affinity DataIC50: 22nMpH: 7.0Assay Description:The test compounds were dissolved in 1% acetic acid and further complemented with an equal volume of DMSO. The resulting stock solutions were seriall...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/18/2019
Entry Details
Go to US Patent

TargetPlasminogen [101-181](Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandPNGBDBM290276(US10098883, Example 17 | 3,4-Dimethyl-8-(piperidin...)
Affinity DataIC50: 22nMAssay Description:The clot-lysis test system configures the kinetics of clot formation and degradation in vitro and allows quantifying modulation of the process by sel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/15/2021
Entry Details
Go to US Patent